Lichen Sclerosus – the Influence on Quality of Life


A randomised controlled trial of Lichen Sclerosus in a period of six months measuring Quality of Life and sexuality among women with Lichen Sclerosus.

Full Title of Study: “Lichen Sclerosus – the Influence on Quality of Life”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Investigator, Outcomes Assessor)
  • Study Primary Completion Date: May 22, 2020

Detailed Description

The patients are randomized to an intervention Group and a control Group. The intervention gets 6-8 visits with clinical sexologist and the control Group is having the usual care.


  • Other: Standard care and sexological counseling
    • 6-8 sexological consultants in a period of six months

Arms, Groups and Cohorts

  • Experimental: Standard care and sexological counseling
    • Standard care including gynecological examination and 6-8 sexological consultations.
  • No Intervention: Standard care
    • Standard care including gynecological examination.

Clinical Trial Outcome Measures

Primary Measures

  • Quality of Life in women with Lichen Sclerosus
    • Time Frame: Six months
    • Change in EuroQol five dimension (EQ-5D) score. The descriptive system comprises 5 dimensions (mobili-ty, self care, usual activities, pain/discomfort, anxiety/depression). However, each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. The answers given to EQ-5D permit to find 243 unique health states or can be converted into EQ-5D index an utility scores anchored at 0 for death and 1 for perfect health.

Participating in This Clinical Trial

Inclusion Criteria

  • Patients diagnosed with Lichen Sclerosus – Age over 18 years Exclusion Criteria:

  • Patients who does not understand or speak Danish – Patients with a psychiatric diagnosis and can not follow the course

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Vendsyssel Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Dorte Melgaard Kristiansen, Research Coordinator – Vendsyssel Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.